JNJ - JOHNSON & JOHNSON
Close
144.47
-0.140 -0.097%
Share volume: 10,376,377
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$144.61
2.41
0.02%
View ratios
| Fiscal Date | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-29 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-04-28 | 2023-07-31 | 2023-10-27 | 2024-02-16 | 2024-05-01 | 2024-07-25 | 2024-10-23 | |
| Total revenue | 24.746 B | 25.530 B | 21.351 B | 13.532 B | 21.383 B | 22.447 B | 22.471 B | |
| Cost of revenue | 8.395 B | 8.212 B | 6.606 B | 3.340 B | 6.511 B | 6.869 B | 6.963 B | |
| Gross profit | 16.351 B | 17.318 B | 14.745 B | 10.192 B | 14.872 B | 15.578 B | 15.508 B | |
| 5.91% | -14.86% | -30.88% | 45.92% | 4.75% | -0.45% | |||
| Operating expenses | 9.701 B | 10.494 B | 8.847 B | 7.555 B | 8.799 B | 9.121 B | 10.430 B | |
| Selling general and admin | 6.138 B | 6.665 B | 5.400 B | 3.309 B | 5.257 B | 5.681 B | 5.478 B | |
| Research and development | 3.563 B | 3.829 B | 3.447 B | 4.246 B | 3.542 B | 3.440 B | 4.952 B | |
| Total expenses | 18.096 B | 18.706 B | 15.453 B | 10.895 B | 15.310 B | 15.990 B | 10.471 B | |
| 3.37% | -17.39% | -29.50% | 40.52% | 4.44% | -34.52% | |||
| Operating income | 6.650 B | 6.824 B | 5.898 B | 2.637 B | 6.073 B | 6.457 B | 5.037 B | |
| Ebit | 6.650 B | 6.824 B | 5.898 B | 2.637 B | 6.073 B | 6.457 B | 3.239 B | |
| Pretax income | -737.000 M | 6.762 B | 5.217 B | 3.820 B | 3.714 B | 5.748 B | 3.338 B | |
| -1,017.50% | -22.85% | -26.78% | -2.77% | 54.77% | -41.93% | |||
| Income tax | -669.000 M | 1.618 B | 908.000 M | -121.000 M | 459.000 M | 1.062 B | 644.000 M | |
| Net income basic | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | 0.000 | |
| 7,664.71% | 405.99% | -84.44% | -19.61% | 43.96% | -100.00% | |||
| Net income | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | 2.694 B | |
| 7,664.71% | 405.99% | -84.44% | -19.61% | 43.96% | -42.51% |